Skip to main content
Fig. 12 | Cancer Imaging

Fig. 12

From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology

Fig. 12

Post-contrast MRI (left) and GaTate-PET (right) images of two different patients with meningiomas refractory to conventional therapy. The skull base meningioma (a; asterisk) demonstrates high GaTate uptake (b) and may benefit from PRRT. In contrast, the left temporal meningioma extending into the orbit (c; arrowheads) has only low-grade GaTate uptake (d), thus PRRT is not warranted

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us